CAAS Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-30,000
Closed -$975K 781
2021
Q1
$975K Buy
+30,000
New +$975K 0.01% 444